API INTERMEDIATES
2-Chloro-1,3-bis(dimentylamino)trimethinium hexafluorophosphate (CAS No.: 249561-98-6)
SS Pharma Group is an ISO 9001:2015 Certified Global Supplier based in India for the product CAS No.: 249561-98-6. We supply this product from our network of trusted manufacturers, suppliers, and principals, catering to your Research and Development, Evaluation, or Commercial requirements based on product availability. We can also provide upstream or downstream intermediates along with a supportive technical package for evaluation upon request.
We respect our customers' stringent regulatory and specification needs, ensuring transparency in offering intermediates. SS Pharma Group prioritizes affordability and high-quality raw material intermediates, making it easy to access reliable manufacturers, suppliers, and principals through our extensive network.
If you are seeking upstream or downstream intermediates related to CAS No.: 249561-98-6, please feel free to email us. Based on your specific requirements, we will source a reliable manufacturer, supplier, or principal that meets your quality standards and aligns with your needs.
CAS number:
249561-98-6
Chemical Name:
N,N-DiMethyl-2-chloro-triMethiniuM Hexafluorophosphate, 2-Chloro-1,3-bis(dimentylamino)trimethinium hexafluorophosphate (CAS No.: 249561-98-6)
Manufacturer Certificate:
GMP, Factory GMP, ISO Certified
| Synonyms | N,N-DiMethyl-2-chloro-triMethiniuM Hexafluorophosphate, 2-Chloro-1,3-bis(dimentylamino)trimethinium hexafluorophosphate (CAS No.: 249561-98-6) |
|---|---|
| Molecular Formula | C7H14ClN2.PF6 |
| Manufacturer Specifications | Available upon request |
| Packing | Export-worthy packing |
| Material Safety Data Sheet | Available on request |
| Product Name | CAS No. |
|---|---|
| Etoricoxib | 202409-33-4 |
| TDP |
|---|
| ✅ |
Send us your Intermediates inquiries to bdteam@sspharma.com
- • Products protected by valid patents from a manufacturer are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk
- • Products currently covered by valid US Patents are offered for R&D use from a manufacturer in accordance with 35 USC 271 +A13(1)
- • Products falling in to controlled substance category / list of schedule drugs shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
- • SS Pharma Group assumes no responsibility/liability in case of being imparted with goods which infringe intellectual property in any manner whatsoever which includes patent rights of any individual manufacturer. SS Pharma Group makes no representations or warranties of any kind, express or implied, about the originality or reliability with respect to the intellectual property which includes patents of a manufacturer in its products or services for any purpose.
- • SS Pharma Group warns the sellers not to sell any goods which infringe intellectual property in any manner whatsoever which includes patent rights of any individual or a manufacturer.
- • SS Pharma Group warns the buyers not to use/procure any goods from a manufacturer to achieve a product which might be knowingly causing an infringement of intellectual property in any manner whatsoever which includes patent rights of any individual manufacturer.
- • This website is updated and maintained by SS Pharma Group. As a matter of policy, SS Pharma Group does not entertain any anonymous or pseudonymous inquiries.
Under Development
| S# | Product Name | Therapeutic Area | QUOTE |
|---|---|---|---|
| 1 | Brivaracetam | Anticonvulsant |  |
| 2 | Bempedoic Acid | Anticoagulant | |
| 3 | Esomeprazole | Gastro-Intestinal | |
| 4 | Levetiracetam | Anticonvulsant | |
| 5 | Ranolazine | Anticoagulant | |
| 6 | Ropinirole Hydrochloride | Antiparkinson | |
| 7 | Rosuvastatin Calcium | Antilipidemic | |
| 8 | Sulindac | Anti-Inflammatory | |
| 9 | Ticagrelor | Anticoagulant | |
| 10 | Varenicline Tartrate | Anti-Smoking | |